Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04479995 · ClinicalTrials.gov registry record · NA

Multidisciplinary Intervention In Chronic GVHD

A NA study of Quality of Life and Graft Vs Host Disease, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04479995: Active NA study of Quality of Life and Graft Vs Host Disease, sponsored by Massachusetts General Hospital.

NCT04479995 is a NA study of Quality of Life and Graft Vs Host Disease that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04479995, a NA study of Quality of Life and Graft Vs Host Disease, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This research is being done to evaluate the feasibility and efficacy of a multidisciplinary, patient-centered intervention, Horizons Program, versus minimally enhanced standard care to improve quality of life, symptom burden and psychological distress of adults who received an allogeneic hematopoietic stem cell transplant and developed graft versus-host disease (GVHD).

Primary Outcome

Feasibility will be demonstrated if ≥50% eligible participants enroll

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Horizon Program

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2020-08-02
Est. Completion 2027-12-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What the registry record for NCT04479995 still lists

NCT04479995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (82% lower).

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04479995 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04479995 about?

NCT04479995 is a clinical study titled "Multidisciplinary Intervention In Chronic GVHD". This research is being done to evaluate the feasibility and efficacy of a multidisciplinary, patient-centered intervention, Horizons Program, versus minimally enhanced standard care to improve quality of life, symptom burden and psychological distress of adults who received an allogeneic hematopoiet...

What is the current status of trial NCT04479995?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2020-08-02. Estimated completion is 2027-12-01.

What conditions does trial NCT04479995 study?

This clinical trial studies the following conditions: Quality of Life, Graft Vs Host Disease, Coping Skills, Stem Cell Transplant Complications.

What interventions are being tested in trial NCT04479995?

The interventions under investigation include: Usual Care (BEHAVIORAL), Horizon Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04479995?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04479995 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04479995's enrollment target sits among peer trials

80 56th of 107 higher than 51 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04479995, the US trial registry maintained by the National Library of Medicine. NCT04479995 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.